| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.
Other companies in Jasper Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Jasper Therapeutics has a consensus price target of $8.39.
The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $0.5 last updated October 13, 2026 at 3:59 PM EDT.
There are no upcoming dividends for Jasper Therapeutics.
Jasper Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Jasper Therapeutics.
Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
